Trial Profile
Comparison of Ketorolac Tromethamine 0.4% and Nepafenac 0.1% for the Prevention of Cystoid Macular Edema After Phacoemulsification: Prospective Randomized Double-masked Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Aug 2015
Price :
$35
*
At a glance
- Drugs Ketorolac (Primary) ; Nepafenac (Primary)
- Indications Retinal oedema
- Focus Therapeutic Use
- 27 Apr 2014 New trial record